242 related articles for article (PubMed ID: 28677618)
1. LPS-Induced Low-Grade Inflammation Increases Hypothalamic JNK Expression and Causes Central Insulin Resistance Irrespective of Body Weight Changes.
Rorato R; Borges BC; Uchoa ET; Antunes-Rodrigues J; Elias CF; Elias LLK
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677618
[TBL] [Abstract][Full Text] [Related]
2. Increase in hypothalamic AMPK phosphorylation induced by prolonged exposure to LPS involves ghrelin and CB1R signaling.
Rivas PMS; Vechiato FMV; Borges BC; Rorato R; Antunes-Rodrigues J; Elias LLK
Horm Behav; 2017 Jul; 93():166-174. PubMed ID: 28576646
[TBL] [Abstract][Full Text] [Related]
3. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation.
Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E
Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863
[TBL] [Abstract][Full Text] [Related]
4. Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids.
Choi SJ; Kim F; Schwartz MW; Wisse BE
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1122-30. PubMed ID: 20354158
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.
Grunewald ZI; Lee S; Kirkland R; Ross M; de La Serre CB
Physiol Behav; 2019 Feb; 199():282-291. PubMed ID: 30502357
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons.
Kowalchuk C; Kanagasundaram P; Belsham DD; Hahn MK
Psychoneuroendocrinology; 2019 Jun; 104():42-48. PubMed ID: 30802709
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase-1B contributes to LPS-induced leptin resistance in male rats.
Borges Bde C; Rorato RC; Uchoa ET; Marangon PB; Elias CF; Antunes-Rodrigues J; Elias LL
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E40-50. PubMed ID: 25352433
[TBL] [Abstract][Full Text] [Related]
8. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion.
Prada PO; Zecchin HG; Gasparetti AL; Torsoni MA; Ueno M; Hirata AE; Corezola do Amaral ME; Höer NF; Boschero AC; Saad MJ
Endocrinology; 2005 Mar; 146(3):1576-87. PubMed ID: 15591151
[TBL] [Abstract][Full Text] [Related]
9. JNK and IKKβ phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats.
Motta K; Barbosa AM; Bobinski F; Boschero AC; Rafacho A
J Steroid Biochem Mol Biol; 2015 Jan; 145():1-12. PubMed ID: 25268311
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
[TBL] [Abstract][Full Text] [Related]
11. αMSH inhibits adipose inflammation via reducing FoxOs transcription and blocking Akt/JNK pathway in mice.
Liu G; Li M; Saeed M; Xu Y; Ren Q; Sun C
Oncotarget; 2017 Jul; 8(29):47642-47654. PubMed ID: 28514752
[TBL] [Abstract][Full Text] [Related]
12. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus.
Barry CE; Nolan Y; Clarke RM; Lynch A; Lynch MA
J Neurochem; 2005 Apr; 93(1):221-31. PubMed ID: 15773921
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
14. Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats.
Oliveira AG; Carvalho BM; Tobar N; Ropelle ER; Pauli JR; Bagarolli RA; Guadagnini D; Carvalheira JB; Saad MJ
Diabetes; 2011 Mar; 60(3):784-96. PubMed ID: 21282367
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.
Rorato R; Reis WL; de Carvalho Borges B; Antunes-Rodrigues J; Elias LL
Neuropharmacology; 2012 Jul; 63(1):154-60. PubMed ID: 22138163
[TBL] [Abstract][Full Text] [Related]
16. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion.
Arruda AP; Milanski M; Coope A; Torsoni AS; Ropelle E; Carvalho DP; Carvalheira JB; Velloso LA
Endocrinology; 2011 Apr; 152(4):1314-26. PubMed ID: 21266511
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in Alzheimer's disease (AD) mouse intestinal macrophages is mediated by activation of JNK.
Zhou YL; Du YF; Du H; Shao P
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1787-1794. PubMed ID: 28485801
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
19. Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues.
Prada PO; Coelho MS; Zecchin HG; Dolnikoff MS; Gasparetti AL; Furukawa LN; Saad MJ; Heimann JC
J Endocrinol; 2005 Jun; 185(3):429-37. PubMed ID: 15930169
[TBL] [Abstract][Full Text] [Related]
20. Atypical protein kinase C activity in the hypothalamus is required for lipopolysaccharide-mediated sickness responses.
Thaler JP; Choi SJ; Sajan MP; Ogimoto K; Nguyen HT; Matsen M; Benoit SC; Wisse BE; Farese RV; Schwartz MW
Endocrinology; 2009 Dec; 150(12):5362-72. PubMed ID: 19819945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
